.gif?ad=16839&adview=true)
![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
Research Papers
Howard Hughes Medical Institute, Duke University Medical Center, Durham, North Carolina 27710.
Abstract
Among eukaryotic transcription trans-activators, the human immunodeficiency virus type 1 (HIV-1) Tat protein is exceptional in that its target site TAR is an RNA rather than a DNA sequence. Here, we confirm that fusion of Tat to the RNA-binding domain of the HIV-1 Rev protein permits the efficient activation of an HIV-1 long terminal repeat (LTR) promoter in which critical TAR sequences have been replaced by RNA sequences derived from the HIV-1 Rev response element (RRE). An RRE target sequence as small as 13 nucleotides is shown to form an effective in vivo target for Rev binding. More important, a fusion protein consisting of Rev attached to the VP16 transcription activation domain was also observed to efficiently activate the HIV-1 LTR from this nascent RNA target. These data demonstrate that trans-activation of transcription by acidic activation domains does not require a stable interaction with the promoter DNA and suggest that VP16, like Tat, can act on steps subsequent to the formation of the HIV-1 LTR preinitiation complex. The finding that the activation domains of VP16 and Tat are functionally interchangeable raises the possibility that these apparently disparate viral trans-activators may nevertheless act via similar mechanisms.
CiteULike 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  C.-L. Hsieh, C. Cai, A. Giwa, A. Bivins, S.-Y. Chen, D. Sabry, K. Govardhan, and L. Shemshedini Expression of a hyperactive androgen receptor leads to androgen-independent growth of prostate cancer cells J. Mol. Endocrinol., July 1, 2008; 41(1): 13 - 23. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Zhu, R. A. Hasman, V. A. Barron, G. Luo, and H. Lou A Nuclear Function of Hu Proteins as Neuron-specific Alternative RNA Processing Regulators Mol. Biol. Cell, December 1, 2006; 17(12): 5105 - 5114. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Zhen, B. Bradel-Tretheway, S. Sumagin, J. M. Bidlack, and S. Dewhurst The Human Herpesvirus 6 G Protein-Coupled Receptor Homolog U51 Positively Regulates Virus Replication and Enhances Cell-Cell Fusion In Vitro J. Virol., September 15, 2005; 79(18): 11914 - 11924. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Fujinaga, D. Irwin, Y. Huang, R. Taube, T. Kurosu, and B. M. Peterlin Dynamics of Human Immunodeficiency Virus Transcription: P-TEFb Phosphorylates RD and Dissociates Negative Effectors from the Transactivation Response Element Mol. Cell. Biol., January 15, 2004; 24(2): 787 - 795. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Fujinaga, D. Irwin, R. Taube, F. Zhang, M. Geyer, and B. M. Peterlin A Minimal Chimera of Human Cyclin T1 and Tat Binds TAR and Activates Human Immunodeficiency Virus Transcription in Murine Cells J. Virol., November 13, 2002; 76(24): 12934 - 12939. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. A. Coburn and B. R. Cullen Potent and Specific Inhibition of Human Immunodeficiency Virus Type 1 Replication by RNA Interference J. Virol., August 12, 2002; 76(18): 9225 - 9231. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. S. Pendergrast, C. Wang, N. Hernandez, and S. Huang FBI-1 Can Stimulate HIV-1 Tat Activity and Is Targeted to a Novel Subnuclear Domain that Includes the Tat-P-TEFb---containing Nuclear Speckles Mol. Biol. Cell, March 1, 2002; 13(3): 915 - 929. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. N. Ho, G. A. Coburn, Y. Kang, B. R. Cullen, and M. M. Georgiadis The crystal structure and mutational analysis of a novel RNA-binding domain found in the human Tap nuclear mRNA export factor PNAS, February 19, 2002; 99(4): 1888 - 1893. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Martin-Serrano, K. Li, and P. D. Bieniasz Cyclin T1 Expression Is Mediated by a Complex and Constitutively Active Promoter and Does Not Limit Human Immunodeficiency Virus Type 1 Tat Function in Unstimulated Primary Lymphocytes J. Virol., January 1, 2002; 76(1): 208 - 219. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. L. Wiegand, G. A. Coburn, Y. Zeng, Y. Kang, H. P. Bogerd, and B. R. Cullen Formation of Tap/NXT1 Heterodimers Activates Tap-Dependent Nuclear mRNA Export by Enhancing Recruitment to Nuclear Pore Complexes Mol. Cell. Biol., January 1, 2002; 22(1): 245 - 256. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. A. Russell, Y. Zeng, O. Erlwein, B. R. Cullen, and M. O. McClure The R Region Found in the Human Foamy Virus Long Terminal Repeat Is Critical for both Gag and Pol Protein Expression J. Virol., August 1, 2001; 75(15): 6817 - 6824. [Abstract] [Full Text]
|
|
|
|
 |
|
 G. A. Coburn, H. L. Wiegand, Y. Kang, D. N. Ho, M. M. Georgiadis, and B. R. Cullen Using viral species specificity to define a critical protein/RNA interaction surface Genes & Dev., May 15, 2001; 15(10): 1194 - 1205. [Abstract] [Full Text]
|
|
|
|
|
|
M. Zhou, M. A. Halanski, M. F. Radonovich, F. Kashanchi, J. Peng, D. H. Price, and J. N. Brady Tat Modifies the Activity of CDK9 To Phosphorylate Serine 5 of the RNA Polymerase II Carboxyl-Terminal Domain during Human Immunodeficiency Virus Type 1 Transcription Mol. Cell. Biol., July 15, 2000; 20(14): 5077 - 5086. [Abstract] [Full Text]
|
|
|
|
|
|
Y. Kang, H. P. Bogerd, and B. R. Cullen Analysis of Cellular Factors That Mediate Nuclear Export of RNAs Bearing the Mason-Pfizer Monkey Virus Constitutive Transport Element J. Virol., July 1, 2000; 74(13): 5863 - 5871. [Abstract] [Full Text]
|
|
|
|
|
|
H. P. Bogerd, H. L. Wiegand, P. D. Bieniasz, and B. R. Cullen Functional Differences between Human and Bovine Immunodeficiency Virus Tat Transcription Factors J. Virol., May 15, 2000; 74(10): 4666 - 4671. [Abstract] [Full Text]
|
|
|
|
|
|
P. D. Bieniasz, T. A. Grdina, H. P. Bogerd, and B. R. Cullen Recruitment of cyclin T1/P-TEFb to an HIV type 1 long terminal repeat promoter proximal RNA target is both necessary and sufficient for full activation of transcription PNAS, July 6, 1999; 96(14): 7791 - 7796. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. D. Bieniasz, T. A. Grdina, H. P. Bogerd, and B. R. Cullen Highly Divergent Lentiviral Tat Proteins Activate Viral Gene Expression by a Common Mechanism Mol. Cell. Biol., July 1, 1999; 19(7): 4592 - 4599. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Kang and B. R. Cullen The human Tap protein is a nuclear mRNA export factor that contains novel RNA-binding and nucleocytoplasmic transport sequences Genes & Dev., May 1, 1999; 13(9): 1126 - 1139. [Abstract] [Full Text]
|
|
|
|
|
|
H. P. Bogerd, A. Echarri, T. M. Ross, and B. R. Cullen Inhibition of Human Immunodeficiency Virus Rev and Human T-Cell Leukemia Virus Rex Function, but Not Mason-Pfizer Monkey Virus Constitutive Transport Element Activity, by a Mutant Human Nucleoporin Targeted to Crm1 J. Virol., November 1, 1998; 72(11): 8627 - 8635. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Heger, O. Rosorius, C. Koch, G. Casari, R. Grassmann, and J. Hauber Multimer Formation Is Not Essential for Nuclear Export of Human T-Cell Leukemia Virus Type 1 Rex trans-Activator Protein J. Virol., November 1, 1998; 72(11): 8659 - 8668. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Daviet, F. Bois, P.-L. Battisti, and A. Gatignol Identification of Limiting Steps for Efficient Trans-activation of HIV-1 Promoter by Tat in Saccharomyces cerevisiae J. Biol. Chem., October 23, 1998; 273(43): 28219 - 28228. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. O. Hottiger and G. J. Nabel Interaction of Human Immunodeficiency Virus Type 1 Tat with the Transcriptional Coactivators p300 and CREB Binding Protein J. Virol., October 1, 1998; 72(10): 8252 - 8256. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Fujinaga, T. P. Cujec, J. Peng, J. Garriga, D. H. Price, X. Grana, and B. M. Peterlin The Ability of Positive Transcription Elongation Factor b To Transactivate Human Immunodeficiency Virus Transcription Depends on a Functional Kinase Domain, Cyclin T1, and Tat J. Virol., September 1, 1998; 72(9): 7154 - 7159. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. O. Gold, X. Yang, C. H. Herrmann, and A. P. Rice PITALRE, the Catalytic Subunit of TAK, Is Required for Human Immunodeficiency Virus Tat Transactivation In Vivo J. Virol., May 1, 1998; 72(5): 4448 - 4453. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. L. Thomas, M. Oft, H. Jaksche, G. Casari, P. Heger, M. Dobrovnik, D. Bevec, and J. Hauber Functional Analysis of the Human Immunodeficiency Virus Type 1 Rev Protein Oligomerization Interface J. Virol., April 1, 1998; 72(4): 2935 - 2944. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B E Meyer and M H Malim The HIV-1 Rev trans-activator shuttles between the nucleus and the cytoplasm. Genes & Dev., July 1, 1994; 8(13): 1538 - 1547. [Abstract] [PDF]
|
|
|
|
|
|
K. K. C. Li and K. A. W. Lee Transcriptional Activation by the Ewing's Sarcoma (EWS) Oncogene Can Be Cis-repressed by the EWS RNA-binding Domain J. Biol. Chem., July 21, 2000; 275(30): 23053 - 23058. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Zhou, S. Nekhai, D. C. Bharucha, A. Kumar, H. Ge, D. H. Price, J.-M. Egly, and J. N. Brady TFIIH Inhibits CDK9 Phosphorylation during Human Immunodeficiency Virus Type 1 Transcription J. Biol. Chem., November 21, 2001; 276(48): 44633 - 44640. [Abstract] [Full Text] [PDF]
|
|
